United States Interventional Neuroradiology Market 2031 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

Global Interventional Neuroradiology Market reached US$ 1.9 billion in 2022 and is expected to reach US$ 2.9 billion by 2031, growing with a CAGR of 5.8% during the forecast period 2024-2031.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/interventional-neuroradiology-market?sb

Key Development:

United States: Recent Interventional Neuroradiology Developments

✅ In December 2025, Vesalio received two US FDA 510(k) clearances for its aspiration devices designed for peripheral and neurovascular thrombectomy, expanding clinical options for clot removal in acute stroke and vascular interventions.
- The clearances support a broader suite of tools for minimally invasive neurovascular procedures and aim to improve procedural outcomes and physician choice in challenging interventions.

✅ In November 2025, late‐breaking real‐world data highlighted the ADAPT 2.0 approach using Imperative Care's Zoom stroke system in mechanical thrombectomy, demonstrating effectiveness in consecutive ischemic stroke patients across US centers.
- This evidence supports refinement of stroke treatment workflows and adoption of advanced thrombectomy strategies within interventional neuroradiology practice.

✅ In November 2025, a novel self‐expandable stent for ICAD‐related large vessel occlusion (LVO) stroke showed an 86.7% rate of significant revascularisation in a multicentre Japanese trial presented at SVIN 2025 indicating clinical impact and cross‐border research influence.
- Though evaluated in Japan, the results presented at a major US interventional neurology meeting reflect innovation relevance to global stroke care paradigms.

✅ In October 2025, Qure.ai's qER‐CTA AI solution received US FDA 510(k) clearance for automated analysis of CTA scans suspected of LVO, potentially enabling faster detection and triage in acute neurointerventional settings.
- This clearance marks a meaningful step toward integrating AI into the diagnostic pathway for stroke and neurovascular emergency workflows.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=interventional-neuroradiology-market

Japan: Recent Interventional Neuroradiology Developments

✅ In December 2025, the East Asian Conference on Neurointervention (EACoN) & KCNI 2025 was announced for December, fostering regional collaboration on minimally invasive neurovascular therapies with hands‐on education and expert sessions.

✅ In November 2025, a novel stent designed for ICAD‐related LVO stroke demonstrated strong safety and efficacy in a multicentre study across Japanese stroke centres, achieving high revascularisation outcomes.
- These findings highlight Japan's clinical leadership in advanced device validation for complex neurovascular pathology.

✅ In November 2025, the 41st Annual Meeting of the Japanese Society of Neuroendovascular Therapy (JSNET) was held in Osaka, bringing together leading clinicians and innovators to share research and procedural advancements.
- This major congress serves as a key forum for the dissemination of cutting‐edge techniques and collaborative research in neurointervention across Japan and the region.
- The event emphasizes collective progress and shared clinical insights, particularly between Japan, Korea, and other Asian specialists in neurointerventional radiology.

✅ In August 2025, the 16th Biennial Congress of the Asian‐Australian Federation of Interventional & Therapeutic Neuroradiology (AAFITN) was held in Bangkok, with strong participation from Japanese practitioners and teaching workshops on advanced endovascular treatments.
- This regional meeting helped disseminate Japanese clinical expertise and fostered international dialogue on evolving INR procedures.

Key Players:

=> Balt Extrusion, Merit Medical Systems, Terumo Corporation, Medtronic, Penumbra, Inc., Mediterra, Stryker, Boston Scientific Corporation, Micro Port Scientific Corporation, MicroVention Inc. and others.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/interventional-neuroradiology-market?sb

Key Segments:

By Device Type

Microcatheters - Leading segment with 25% share, widely used for precise navigation in neurovascular interventions.
Neurovascular Embolization & Coiling Assist Devices - 20% share, essential for supporting coil deployment in cerebral aneurysms.
Embolic Coils - 18% share, standard devices for aneurysm treatment with established clinical efficacy.
Flow Diversion Devices - 15% share, rapidly growing due to adoption in complex aneurysm cases.
Liquid Embolic Agents - 10% share, used for vascular malformations and arteriovenous fistulas.
Accessories - 7% share, includes catheters, delivery systems, and support devices.
Microguidewires - 5% share, critical for device navigation in minimally invasive procedures.

By Application

Cerebral Aneurysms - 45% share, primary application driving device adoption globally.
Intra-cranial Atherosclerotic Tumors - 20% share, growing due to rising prevalence of neurovascular disorders.
Acute Ischemic Strokes - 25% share, increasing adoption with thrombectomy and embolization techniques.
Others - 10% share, includes vascular malformations and off-label neurovascular interventions.

By End-User

Hospitals - 60% share, largest end-user due to availability of specialized neurovascular intervention units.
Ambulatory Surgical Centers - 20% share, gaining traction for minimally invasive procedures.
Diagnostic Centers - 20% share, supporting procedures with imaging guidance and pre/post-operative care.

By Region

North America - 35% Share
High adoption driven by advanced neurointerventional infrastructure, skilled workforce, and reimbursement support.

Europe - 25% Share
Steady growth with strong hospital infrastructure and increasing awareness of neurovascular diseases.

Asia-Pacific - 25% Share
Rising prevalence of stroke and aneurysms, along with expanding healthcare infrastructure, drives demand.

Latin America - 10% Share
Moderate growth due to increasing investments in hospital and surgical infrastructure.

Middle East & Africa - 5% Share
Emerging adoption with focus on specialized hospitals and urban centers.

FAQ

What is the current size of the Interventional Neuroradiology Market?

A: In 2022, the Interventional Neuroradiology Market was valued at US$ 1.9 billion , reflecting its strong industry presence.

Q2: How large is the Interventional Neuroradiology Market expected to be by 2031?

A: By 2031, industry forecasts suggest the Interventional Neuroradiology Market will grow to around US$ 2.9 billion, demonstrating significant expansion.

Q3: What is the growth rate of the Interventional Neuroradiology Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 5.8% during the forecast period from 2024 to 2031.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.